Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...
Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States ...
A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.
The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...
A new study on the genetic causes of the PTEN Hamartoma Tumour Syndrome (PHTS) has found that inhibitors of the PI3ka pathway, commonly used as anticancer drugs, are also effective against this ...